Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
MannKind (Nasdaq:MNKD) announced today that it received FDA approval, updating the prescribing information for Afrezza ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results